株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

体外診断(IVD)向け包装の世界市場:成長、動向、予測(2019年~2024年)

In-vitro Diagnostics (IVD) Packaging Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 394601
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.80円で換算しております。
Back to Top
体外診断(IVD)向け包装の世界市場:成長、動向、予測(2019年~2024年) In-vitro Diagnostics (IVD) Packaging Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年01月01日 ページ情報: 英文 120 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

世界の体外診断(IVD)向け包装市場は、2019年から2024年の間に4.37%のCAGRで成長すると予測されています。

当レポートは世界の体外診断(IVD)向け包装市場について調査しており、市場の機会や動向、成長および阻害要因、製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査の成果
  • 調査の仮定
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場の成長および阻害要因の概要
  • 市場成長要因
  • 市場の阻害要因
  • 業界の魅力:ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競合情勢

第5章 市場セグメント

  • 製品別
    • ボトル
    • バイアル
    • チューブ
    • クロージャ―
    • その他
  • エンドユーザー別
    • 病院
    • 研究所
    • 学術機関
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東およびアフリカ地域

第6章 競合情勢

  • 企業プロファイル
    • Amcor Limited
    • Aptargroup Incorporated
    • Corning Incorporated
    • Greiner Holding AG
    • Thermo Fisher Scientific Incorporated
    • COMAR, LLC.
    • WS Packaging Group
    • DWK Life Sciences

第7章 投資分析

第8章 市場機会および将来動向

目次
Product Code: 48607

Market Overview

The In-vitro Diagnostics (IVD) Packaging market was valued at USD 7.22 billion in 2019 and is expected to reach USD 9.52 billion by 2025, at a CAGR of 4.5% over the forecast period 2020 - 2025. The global in vitro diagnostic packaging market is booming mainly due to technological advancements, enhanced diagnostic tools, and increased availability of over-the-counter tests.

  • The rapidly rising practice of self-testing by the people, an increasing number of point-of-care testing, increased government expenditures on healthcare, growing awareness of personalized medicine and the increasing number of chronic diseases are some of the major factors boosting the growth of the in vitro diagnostics (IVD) packaging market.
  • The importance of IVD packaging is increasing in the healthcare sector owing to the demand for faster diagnosis time and increased volume of samples obtained by the automation devices. This has resulted in the increased usage of IVD devices in hospitals.
  • Other contributing factors boosting the growth of the market include the pressure from the governments and industries across the globe, to comply with the set regulations, due to the increasing demand for integrated healthcare systems. For instance, the FDA uses a risk-based regulatory scheme for medical devices (including IVDs).

Scope of the Report

In vitro diagnostics are tests done on samples such as blood or tissue that are taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can also be used to monitor a person's overall health to help cure, treat, or prevent diseases.

Key Market Trends

Laboratories Segment to Witness High Growth

  • As the hospitals and laboratories are some of the major consumers of in vitro diagnostic devices, the increasing revenues of these sectors are also expected to develop the market for IVD packaging across the globe.
  • With the shift from the legacy systems to the commercial solutions favored by the laboratories, the market is expected to grow further as they provide a flexible and reliable method to manage data, resources, and workflows.
  • Many governments across the globe are also regulating policies for laboratories having IVDs. For instance, in May 2018, Australia's Therapeutic Goods Administration (TGA) unveiled guidance for laboratories to meet in vitro diagnostics (IVD) regulatory requirements.
  • Moreover, the ongoing shift towards personalized medical devices is expected to create a demand for IVD devices. Also, the innovations in IVD devices are likely to accelerate the demand for IVD packaging during the forecast period.

Asia-Pacific to Witness High Growth

  • The Chinese government is increasing there healthcare expenditure primarily to focus on public health. With the increasing number of hospitals in China, it is justifying their investment in public health initiative, which is driving the market in this region.
  • Moreover, Japan has faced the challenges of shrinking and aging population for several years. The latest population estimate by the Health, Labor, and Welfare Ministry, released in December 2018, points to the rapid decline of Japan's population with fewer births. The number of babies born in the country, in 2018, is estimated at 921,000, which is 25,000 less than the previous year and falling short of 1 million for the third year in a row. These circumstances in the country have accelerated healthcare spending in the region.
  • India is also considered as a lucrative market for generic R&D activities and manufacturing of pharmaceuticals, owing to its strong capabilities across the value chain. Moreover, India's competitive advantage also resides in the magnified success rate of Indian companies in getting the Abbreviated New Drug Application (ANDA) approvals, which is boosting the market growth.

Competitive Landscape

The in-vitro diagnostics (IVD) packaging market is competitive due to the presence of many players running their business in domestic as well as in international markets. The market is moderately concentrated with the major players adopting strategies like product innovation and mergers and acquisitions. Some of the major players in the market are Amcor Limited, Aptargroup Incorporated, Thermo Fisher Scientific Incorporated among others.

  • June 2019 - Amcor announced the successful completion of its acquisition of Bemis Company Inc. The combined company will now operate as Amcor Plc (Amcor). The acquisition of Bemis brings additional scale, capabilities, and footprint that will strengthen Amcor's industry-leading value proposition

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 Growing Demand for Tubes
    • 4.3.2 Increasing Number of Point-of-care Tests
  • 4.4 Market Restraints
    • 4.4.1 Environmental Concerns Related to Raw Materials for Packaging
  • 4.5 Industry Attractiveness - Porter's Five Force Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Bottles
    • 5.1.2 Vials
    • 5.1.3 Tubes
    • 5.1.4 Closures
    • 5.1.5 Other Product Types
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Laboratories
    • 5.2.3 Academic Institutes
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia-Pacific
    • 5.3.4 Latin America
    • 5.3.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amcor Limited
    • 6.1.2 Aptargroup Incorporated
    • 6.1.3 Corning Incorporated
    • 6.1.4 Greiner Holding AG
    • 6.1.5 Thermo Fisher Scientific Incorporated
    • 6.1.6 COMAR, LLC.
    • 6.1.7 WS Packaging Group
    • 6.1.8 DWK Life Sciences

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top